Class III
Terminated
Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1
Why: Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.
- Company
- Gilead Sciences, Inc.
Foster City, CA, United States - Reported
- Oct 15, 2014
- Recall started
- Sep 30, 2014
- Ended
- May 11, 2015
- Where sold
- Nationwide
- Amount
- 10,317 bottles
- Full product description
- Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1
- Lots / codes affected
- TRUVADA (NDA 21-752; NDC 61958-0701-1) Lot# 002808, Expiration Date: 31 December 2017
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.